The transaction was completed with a group of strategic investors led by Catheter Precision, Inc. (NYSE:VTAK), the parent company of Flyte, a technology-enabled regional air mobility platform.

The Company issued an aggregate of 6.5 million shares of common stock in the transaction, generating approximately $2.2 million in gross proceeds.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.